Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ThermaClear

Executive Summary

FDA has given clearance to Therative to market its ThermaClear hand-held acne treatment device, the company announces Jan. 16. Therative has also finished an additional round of expansion funding in anticipation of the product's launch, raising $5 mil. from three venture capital firms. ThermaClear is designed for home treatment of mild-to-moderate acne. It utilizes proprietary technology based on the laser treatments used by dermatologists. The device wears the start-up's first consumer brand; it will be launched in a line that includes a number of topical acne treatment products...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS014487

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel